scispace - formally typeset
Open AccessJournal ArticleDOI

Molecular genetics of prostate cancer: new prospects for old challenges

Michael M. Shen, +1 more
- 15 Sep 2010 - 
- Vol. 24, Iss: 18, pp 1967-2000
TLDR
An overview of major themes in prostate cancer research is presented, focusing on current knowledge of principal events in cancer initiation and progression, including new insights into the mechanisms of castration resistance, identification of stem cells and tumor-initiating cells, and development of mouse models for preclinical evaluation of novel therapuetics.
Abstract
Despite much recent progress, prostate cancer continues to represent a major cause of cancer-related mortality and morbidity in men. Since early studies on the role of the androgen receptor that led to the advent of androgen deprivation therapy in the 1940s, there has long been intensive interest in the basic mechanisms underlying prostate cancer initiation and progression, as well as the potential to target these processes for therapeutic intervention. Here, we present an overview of major themes in prostate cancer research, focusing on current knowledge of principal events in cancer initiation and progression. We discuss recent advances, including new insights into the mechanisms of castration resistance, identification of stem cells and tumor-initiating cells, and development of mouse models for preclinical evaluation of novel therapuetics. Overall, we highlight the tremendous research progress made in recent years, and underscore the challenges that lie ahead.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures

TL;DR: A 3D culture system that supports long-term expansion of primary mouse and human prostate organoids, composed of fully differentiated CK5+ basal and CK8+ luminal cells is described, which supports a luminal multilineage progenitor cell model for prostate tissue and establishes a robust, scalable system for mechanistic studies.
Journal ArticleDOI

Effective combinatorial immunotherapy for castration-resistant prostate cancer.

TL;DR: A novel chimaeric mouse model of mCRPC is developed to efficiently test combination therapies in an autochthonous setting and illuminate a clinical path hypothesis for combining immune checkpoint blockade with MDSC-targeted therapies in the treatment of m CRPC.
Journal ArticleDOI

Genetics and biology of prostate cancer.

TL;DR: Improved disease management will also benefit from artificial intelligence-based expert decision support systems for proper standard of care, prognostic determinant biomarkers to minimize overtreatment of localized disease, and new standards of care accelerated by next-generation adaptive clinical trials.
References
More filters
Journal ArticleDOI

MicroRNA expression profiles classify human cancers

TL;DR: A new, bead-based flow cytometric miRNA expression profiling method is used to present a systematic expression analysis of 217 mammalian miRNAs from 334 samples, including multiple human cancers, and finds the miRNA profiles are surprisingly informative, reflecting the developmental lineage and differentiation state of the tumours.
Journal ArticleDOI

Stem cells, cancer, and cancer stem cells

TL;DR: Stem cell biology has come of age: Unequivocal proof that stem cells exist in the haematopoietic system has given way to the prospective isolation of several tissue-specific stem and progenitor cells, the initial delineation of their properties and expressed genetic programmes, and the beginnings of their utility in regenerative medicine.
Journal ArticleDOI

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

TL;DR: When given with prednisone, treatment with docetaxel every three weeks led to superior survival and improved rates of response in terms of pain, serum PSA level, and quality of life, as compared with mitoxantrone plusprednisone.
Related Papers (5)

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +311 more
- 05 Nov 2015 -